Mary Gates
Impact in
-
- Neuroscience and Neuropharmacology Research
Papers in
-
- Melanoma and MAPK Pathways 4
- Protein Degradation and Inhibitors 3
- Oncology 12
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- David Bleakman (8 shared papers)Paul L. Ornstein (5 shared papers)Ken H. Ho (4 shared papers)Ann Marie L. Ogden (3 shared papers)David Lodge (2 shared papers)Peter Miu (3 shared papers)Luna Musib (10 shared papers)Graham L. Collingridge (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (5 papers)Journal of Medicinal Chemistry (2 papers)Drug Metabolism and Disposition (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Mary Gates
35 papers receiving 984 citations
Peers
Comparison fields: 5 of 79
- Cellular and Molecular Neuroscience 494
- Biological Psychiatry 18
- Molecular Biology 507
- Oncology 182
- Developmental Neuroscience 26
Countries citing papers authored by Mary Gates
This map shows the geographic impact of Mary Gates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Gates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Gates more than expected).
Fields of papers citing papers by Mary Gates
This network shows the impact of papers produced by Mary Gates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Gates. The network helps show where Mary Gates may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Gates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 266 | |
| 2 | 2003 | 90 | |
| 3 | 2019 | 77 | |
| 4 | 2001 | 63 | |
| 5 | 2000 | 62 | |
| 6 | 2012 | 42 | |
| 7 | 2011 | 40 | |
| 8 | 2015 | 38 | |
| 9 | 2020 | 36 | |
| 10 | 2001 | 31 | |
| 11 | 2002 | 31 | |
| 12 | 2018 | 29 | |
| 13 | 2021 | 28 | |
| 14 | 2001 | 25 | |
| 15 | 1997 | 23 | |
| 16 | 2011 | 18 | |
| 17 | 2021 | 17 | |
| 18 | 2022 | 15 | |
| 19 | 2022 | 11 | |
| 20 | 2013 | 9 |
About Mary Gates
Mary Gates is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience and Genetics, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (9 papers), Advanced Breast Cancer Therapies (9 papers), Cancer Treatment and Pharmacology (6 papers), Estrogen and related hormone effects (5 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Melanoma and MAPK Pathways (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (494 citations), Biological Psychiatry (18 citations), Molecular Biology (507 citations), Oncology (182 citations) and Developmental Neuroscience (26 citations). Mary Gates has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David Bleakman, Paul L. Ornstein, Ken H. Ho, Ann Marie L. Ogden, David Lodge, Peter Miu, Luna Musib, Graham L. Collingridge, Ilse Smolders and Bradford T. Brinton. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Medicinal Chemistry, Drug Metabolism and Disposition and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.